Estimates Revisions Entrada Therapeutics, Inc.
Stocks
TRDA
US29384C1080
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 7.300 USD | +3.25% |
|
+4.29% | -28.99% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- TRDA Stock
- Consensus Entrada Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
